Immix Biopharma (IMMX) Research & Development (2021 - 2026)
Immix Biopharma's Research & Development came in at $5.33 million for Q2 2026, up 34.3% from $3.97 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Research & Development (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immix Biopharma reported Research & Development of $21.62 million, up 83.8% year-over-year; for FY2025, it was $16.26 million, up 44.0% from FY2024.
- Research & Development has increased in each of the last three years, with a five-year compound annual growth rate of 130.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $11.29 million in FY2024 (+29.3%), $8.74 million in FY2023 (+108.2%), $4.2 million in FY2022 and $126,527 in FY2021 (-49.0%).
- The five-year range for quarterly Research & Development is $9,236 (Q4 2021) to $5.98 million (Q1 2026).
- Year-over-year, Research & Development has increased for five consecutive quarters, with growth averaging 81.5% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q2 2022 (growth of 868.4%), and the weakest in Q4 2024 (a decline of 55.7%).
- Business Quant data shows IMMX's Research & Development at $5.98 million (Q1 2026), $5.73 million (Q4 2025) and $4.58 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 5.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33 Mn |
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 5.73 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Sep 30, 2022 | 695,937.00 |
| Jun 30, 2022 | 607,751.00 |
| Mar 31, 2022 | 629,531.00 |
| Dec 31, 2021 | 9,236.00 |
| Sep 30, 2021 | 29,690.00 |
API Access
Immix Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();